NO20060958L - Farmasoytisk preparat - Google Patents
Farmasoytisk preparatInfo
- Publication number
- NO20060958L NO20060958L NO20060958A NO20060958A NO20060958L NO 20060958 L NO20060958 L NO 20060958L NO 20060958 A NO20060958 A NO 20060958A NO 20060958 A NO20060958 A NO 20060958A NO 20060958 L NO20060958 L NO 20060958L
- Authority
- NO
- Norway
- Prior art keywords
- selective
- reuptake inhibitor
- antidepressant
- noradrenaline reuptake
- inhibitor
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 3
- 229940126569 noradrenaline reuptake inhibitor Drugs 0.000 abstract 3
- 102000007471 Adenosine A2A receptor Human genes 0.000 abstract 1
- 108010085277 Adenosine A2A receptor Proteins 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 abstract 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- IQVRBWUUXZMOPW-PKNBQFBNSA-N istradefylline Chemical compound CN1C=2C(=O)N(CC)C(=O)N(CC)C=2N=C1\C=C\C1=CC=C(OC)C(OC)=C1 IQVRBWUUXZMOPW-PKNBQFBNSA-N 0.000 abstract 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 abstract 1
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 abstract 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 abstract 1
- 229940127228 tetracyclic antidepressant Drugs 0.000 abstract 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det beskrives farmasøytiske preparater som er nyttige for behandling av depresjon og lignende, og som omfatter en forbindelse med en adenosin A2A reseptor antagonistisk aktivitet som (E)-8-(3,4-dimetoksystyryl)- 1,3-dietyl-7-metyl-3,7-dihydro-lH-purin-2,6dion eller et farmasøytisk akseptabelt salt derav og et antidepressivum, for eksempel et tricyklisk antidepressivum, et tetracyklisk antidepressivum, en selektiv serotonin gjenopptaksinhibitor, en selektiv noradrenalin gjenopptaksinhibitor, en dopamin gjenopptaksinhibitor, en serotonin-noradrenalin gjenopptaksinhibitor, en monoaminoksidaseinhibitor, en 5-HT2 antagonist eller lignende.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003201549 | 2003-07-25 | ||
PCT/JP2004/010758 WO2005009444A1 (ja) | 2003-07-25 | 2004-07-22 | 医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060958L true NO20060958L (no) | 2006-04-25 |
Family
ID=34100521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060958A NO20060958L (no) | 2003-07-25 | 2006-02-27 | Farmasoytisk preparat |
Country Status (8)
Country | Link |
---|---|
US (3) | US8034820B2 (no) |
EP (1) | EP1655029B1 (no) |
JP (1) | JP4648193B2 (no) |
CA (1) | CA2533117C (no) |
ES (1) | ES2634026T3 (no) |
NO (1) | NO20060958L (no) |
TW (1) | TW200507850A (no) |
WO (1) | WO2005009444A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA200400982A1 (ru) * | 2002-01-28 | 2004-12-30 | Киова Хакко Когио Ко., Лтд. | Способы лечения пациентов, страдающих от нарушения движений |
CA2653012C (en) * | 2006-06-19 | 2014-08-05 | Newron Pharmaceuticals S.P.A. | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino) propan amides |
CN101896456B (zh) | 2007-12-11 | 2014-10-22 | 纽朗制药有限公司 | 具有高纯度的2-[4-(3-或2-氟苄氧基)苄氨基]丙酰胺类的生产方法 |
AU2010310595B2 (en) | 2009-10-23 | 2015-07-16 | Janssen Pharmaceutica Nv | Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
WO2011107922A2 (en) * | 2010-03-04 | 2011-09-09 | Ranbaxy Laboratories Limited | Extended release composition of milnacipran |
KR102309836B1 (ko) | 2013-07-18 | 2021-10-12 | 에스케이바이오팜 주식회사 | 비만의 치료 |
HUE058759T2 (hu) * | 2016-03-10 | 2022-09-28 | Janssen Pharmaceutica Nv | Módszerek depresszió kezelésére orexin-2 receptor antagonisták alkalmazásával |
US10388368B2 (en) * | 2017-10-31 | 2019-08-20 | Seagate Technology Llc | Adaptive read threshold voltage tracking with charge leakage mitigation using charge leakage settling time |
CN108714144A (zh) * | 2018-06-08 | 2018-10-30 | 华益药业科技(安徽)有限公司 | 一种度硫平片及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
JP2928386B2 (ja) * | 1992-07-08 | 1999-08-03 | 協和醗酵工業株式会社 | うつ病治療剤 |
ATE325610T1 (de) * | 1997-09-05 | 2006-06-15 | Kyowa Hakko Kogyo Kk | Xanthinderivative zur behandlung von hirnischämie |
EP1379269B1 (en) * | 2001-04-09 | 2009-03-04 | Neurosearch A/S | Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
MXPA04002389A (es) * | 2001-09-13 | 2004-05-31 | Schering Corp | Combinacion de un antagonista del receptor de adenosian a2a y un antidepresivo o ansiolitico. |
MXPA04005158A (es) * | 2001-11-30 | 2004-08-11 | Schering Corp | Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol. |
EA200400982A1 (ru) * | 2002-01-28 | 2004-12-30 | Киова Хакко Когио Ко., Лтд. | Способы лечения пациентов, страдающих от нарушения движений |
GB0204607D0 (en) * | 2002-02-27 | 2002-04-10 | Matrix Lab Ltd | Process |
KR100502905B1 (ko) | 2002-05-30 | 2005-07-25 | 삼성에스디아이 주식회사 | 플라즈마 디스플레이 패널의 구동 장치 및 구동 방법 |
-
2004
- 2004-07-19 TW TW093121448A patent/TW200507850A/zh unknown
- 2004-07-22 ES ES04748023.1T patent/ES2634026T3/es active Active
- 2004-07-22 US US10/565,239 patent/US8034820B2/en not_active Expired - Fee Related
- 2004-07-22 JP JP2005512077A patent/JP4648193B2/ja not_active Expired - Fee Related
- 2004-07-22 EP EP04748023.1A patent/EP1655029B1/en not_active Not-in-force
- 2004-07-22 WO PCT/JP2004/010758 patent/WO2005009444A1/ja active Application Filing
- 2004-07-22 CA CA2533117A patent/CA2533117C/en not_active Expired - Fee Related
-
2006
- 2006-02-27 NO NO20060958A patent/NO20060958L/no not_active Application Discontinuation
-
2011
- 2011-09-16 US US13/234,355 patent/US8440678B2/en not_active Expired - Fee Related
-
2013
- 2013-04-24 US US13/869,076 patent/US9238033B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20130237526A1 (en) | 2013-09-12 |
US9238033B2 (en) | 2016-01-19 |
US8034820B2 (en) | 2011-10-11 |
US20060241102A1 (en) | 2006-10-26 |
EP1655029B1 (en) | 2017-06-14 |
EP1655029A1 (en) | 2006-05-10 |
CA2533117A1 (en) | 2005-02-03 |
EP1655029A4 (en) | 2010-01-13 |
JPWO2005009444A1 (ja) | 2006-09-07 |
US8440678B2 (en) | 2013-05-14 |
US20120010225A1 (en) | 2012-01-12 |
ES2634026T3 (es) | 2017-09-26 |
CA2533117C (en) | 2013-07-02 |
TW200507850A (en) | 2005-03-01 |
JP4648193B2 (ja) | 2011-03-09 |
WO2005009444A1 (ja) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060958L (no) | Farmasoytisk preparat | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
AR053301A1 (es) | Derivados de pirazina y su uso farmaceutico | |
NO20085257L (no) | Purinonderivater som HM74a-agonister | |
BRPI0607532A2 (pt) | derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c | |
NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist | |
TW200510339A (en) | HIV replication inhibiting pyrimidines and triazines | |
CY1110746T1 (el) | Ετεροαρωματικες ενωσεις κινολινης και χρηση αυτων ως αναστολεις pde10 | |
NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
NO20070588L (no) | Piperidinderivater som NK1-antagonister. | |
NO20084257L (no) | Diketopiperazin og piperidin derivater som antivirale midler | |
ATE377589T1 (de) | 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten | |
AR076550A1 (es) | Inhibidores de la janus tirosina kinasa (jak) | |
UY27870A1 (es) | Nuevos derivados de quinuclidina-amida | |
WO2005079756A3 (en) | Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions | |
WO2005003101A3 (en) | Pyrazine and pyridine derivatives as rho kinase inhibitors | |
NO20092021L (no) | Faste former inneholdende 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluor-fenylamino)-9H-purin-2-ylamino]-cykloheksan-1-ol, sammensetninger derav og anvendelse derav | |
WO2008077557A8 (en) | 8-ethinylxanthine derivatives as selective a2a receptor antagonists | |
DK1699459T3 (da) | Fremgangsmåde til behandling af multipel sclerose | |
WO2007044796A3 (en) | Pyridazinone compounds as calcilytics | |
DE60302157D1 (de) | Opioidrezeptorantagonisten | |
WO2005123755A3 (en) | Purine nucleotide derivatives | |
NO20065551L (no) | Anvendelse av opoid reseptor antagonistforbindelser for forhindring og/eller behandling av sykdommer assosiert med malet calcineurin | |
Strödke et al. | Synthesis of Desaza Analogues of Annomontine and Canthin‐4‐one Alkaloids | |
DK1622908T3 (da) | Xanthin-derivater som A2B adenosin-receptor-antagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |